Rapid and Specific Detection of Oxidized LDL/β2GPI Complexes Via Facile Lateral Flow Immunoassay

Overview

Journal Heliyon

Specialty Social Sciences

Date 2020 Jun 20

PMID 32551380

Citations 3

Authors

Xian Wen Tan

Fumiaki Takenaka

Hironori Takekawa

Eiji Mastuura

Affiliations

Soon will be listed here.

Abstract

β2-Glycoprotein I (β2GPI) forms indissociable complex with oxidized LDL (oxLDL) into proatherogenic oxLDL/β2GPI complex through a specific ligand known as 7-ketocholesteryl-9-carboxynonanoate (oxLig-1). Recent discoveries have demonstrated the atherogenicity of these complexes in patients of both systemic and non-systemic autoimmune diseases. Hence, serological level of oxLDL/β2GPI complexes may represent one crucial clinical parameter for disease prognosis of atherosclerosis-related diseases. Herein, we established a simple, specific and rapid gold nanoparticle (GNP) based lateral flow immunoassay (LFIA) to quantify oxLDL/β2GPI complexes from test samples. Specificities of hybridoma cell-derived monoclonal antibodies against antigen, optimal conditions for conjugation of antibody with GNP, and sensitivity of oxLDL/β2GPI LFIA in comparison to an ELISA-based detection method were assessed accordingly. The established oxLDL/β2GPI LFIA was capable of detecting oxLDL/β2GPI specifically without interference from autoantibodies and solitary components of oxLDL/β2GPI present in test samples. A significant correlation (R > 0.8) was also obtained with the oxLDL/β2GPI LFIA when compared to the ELISA-based detection. On the whole, the oxLDL/β2GPI LFIA remains advantageous over the oxLDL/β2GPI ELISA. The unnecessary washing step, short developmental and analytical time support facile and rapid detection of oxLDL/β2GPI as opposed to the laborious ELISA system.

Citing Articles

A novel electrochemical aptasensor based on NrGO-H-MnO NPs integrated CRISPR/Cas12a system for ultrasensitive low-density lipoprotein determination.

Li G, Li S, Li X, He W, Tan X, Liang J Mikrochim Acta. 2024; 191(9):547.

PMID: 39162876 DOI: 10.1007/s00604-024-06628-2.

The Role of Potential Oxidative Biomarkers in the Prognosis of Acute Ischemic Stroke and the Exploration of Antioxidants as Possible Preventive and Treatment Options.

Kamal F, Lefter R, Jaber H, Balmus I, Ciobica A, Iordache A Int J Mol Sci. 2023; 24(7).

PMID: 37047362 PMC: 10094154. DOI: 10.3390/ijms24076389.

Antioxidative attributes of rice bran extracts in ameliorative effects of atherosclerosis-associated risk factors.

Tan X, Kobayashi K, Shen L, Inagaki J, Ide M, Hwang S Heliyon. 2020; 6(12):e05743.

PMID: 33376820 PMC: 7758525. DOI: 10.1016/j.heliyon.2020.e05743.

References

Kosack C, Page A, Klatser P . A guide to aid the selection of diagnostic tests. Bull World Health Organ. 2017; 95(9):639-645. PMC: 5578377. DOI: 10.2471/BLT.16.187468. View

Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T . Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol. 1992; 148(12):3885-91. View

Kasahara J, Kobayashi K, Maeshima Y, Yamasaki Y, Yasuda T, Matsuura E . Clinical significance of serum oxidized low-density lipoprotein/beta2-glycoprotein I complexes in patients with chronic renal diseases. Nephron Clin Pract. 2004; 98(1):c15-24. DOI: 10.1159/000079923. View

Koczula K, Gallotta A . Lateral flow assays. Essays Biochem. 2016; 60(1):111-20. PMC: 4986465. DOI: 10.1042/EBC20150012. View

Morita S . Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis. Biol Pharm Bull. 2016; 39(1):1-24. DOI: 10.1248/bpb.b15-00716. View

Ohkawa H, Ohishi N, Yagi K . Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-8. DOI: 10.1016/0003-2697(79)90738-3. View

Hughes G, Harris N, Gharavi A . The anticardiolipin syndrome. J Rheumatol. 1986; 13(3):486-9. View

Hansson G . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352(16):1685-95. DOI: 10.1056/NEJMra043430. View

Yamaguchi Y, Seta N, Kaburaki J, Kobayashi K, Matsuura E, Kuwana M . Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Blood. 2007; 110(13):4312-8. DOI: 10.1182/blood-2007-07-100008. View

10.

Lee N, BREWER Jr H, Osborne Jr J . beta 2-Glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J Biol Chem. 1983; 258(8):4765-70. View

11.

Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T . Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990; 336(8708):177-8. DOI: 10.1016/0140-6736(90)91697-9. View

12.

Ruiz G, Tripathi K, Okyem S, Driskell J . pH Impacts the Orientation of Antibody Adsorbed onto Gold Nanoparticles. Bioconjug Chem. 2019; 30(4):1182-1191. DOI: 10.1021/acs.bioconjchem.9b00123. View

13.

Segrest J, Jones M, De Loof H, Dashti N . Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res. 2001; 42(9):1346-67. View

14.

Swinkels D, Demacker P . Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res. 1987; 28(10):1233-9. View

15.

McNeil H, Simpson R, Chesterman C, Krilis S . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990; 87(11):4120-4. PMC: 54059. DOI: 10.1073/pnas.87.11.4120. View

16.

Kobayashi K, Kishi M, Atsumi T, Bertolaccini M, Makino H, Sakairi N . Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. J Lipid Res. 2003; 44(4):716-26. DOI: 10.1194/jlr.M200329-JLR200. View

17.

Hunt J, Krilis S . The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol. 1994; 152(2):653-9. View

18.

Virella G, Virella I, Leman R, Pryor M, Lopes-Virella M . Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res. 1993; 23(2):95-101. DOI: 10.1007/BF02592290. View

19.

Kajiwara T, Yasuda T, Matsuura E . Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. J Autoimmun. 2007; 29(2-3):164-73. DOI: 10.1016/j.jaut.2007.07.003. View

20.

Mooradian A . Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009; 5(3):150-9. DOI: 10.1038/ncpendmet1066. View